The DOI matches its Crossref record; 85 of the 92 references it cites were found in a registry or an index.
Severity of Withdrawal Symptoms, Plasma Oxytocin Levels, and Treatment Outcome in Heroin Users Undergoing Acute Withdrawal
Abstract
Pre-clinical studies show that, following chronic opioid exposure, oxytocin neurons exhibit over-excitation upon withdrawal, causing an increase in oxytocin brain and plasma levels. Relevant clinical data on humans are scarce. This study investigates the opioid withdrawal stress effect on oxytocin plasma levels in humans. We evaluated 57 male chronic heroin users in a residential detoxification program. We determined plasma oxytocin levels by ELISA and measured the stress effects of withdrawal using the COWS scale for opioid withdrawal, the VAS scale for craving, and the Hamilton scales for anxiety and depression on the second day of admission. Out of the 57 patients enrolled in the study, 27 completed the 21-day program, while the remaining 30 dropped out prior to completion. Plasma oxytocin levels were significantly higher in those individuals who dropped out than in those who completed the program. Participants who dropped out at some stage scored higher in the COWS, VAS-Craving, and Hamilton-anxiety scales, indicating a higher stress and explaining the higher oxytocin levels. In addition, plasma oxytocin levels correlated positively with the scores achieved in the COWS and Hamilton-anxiety scales. Higher withdrawal stress levels are associated with higher plasma oxytocin levels and early treatment discharge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Journal of the National Medical Association
(2010) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30622-2 · Cited by 5,325
A critical review of visual analogue scales in the measurement of clinical phenomena
Wewers, M. E., & Lowe, N. K. (1990) · Research in Nursing & Health · doi:10.1002/nur.4770130405 · Cited by 2,580
The Cochrane Database of Systematic Reviews
Handoll, H. H. (2004) · The British Journal of Hand Therapy · doi:10.1177/175899830400900201 · Cited by 1,513
The Clinical Opiate Withdrawal Scale (COWS)
Wesson, D. R., & Ling, W. (2003) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2003.10400007 · Cited by 1,120
Landgraf, R., & Neumann, I. D. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.05.001 · Cited by 1,059
Dendritic peptide release and peptide-dependent behaviours
Ludwig, M., & Leng, G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1845 · Cited by 945
Weddington, W. W., & McLellan, A. T. (1994) · Psychiatric Services · doi:10.1176/ps.45.1.80 · Cited by 839
Research works printed but not linked: 8
- 10.1111/adb.2010.15.issue-4 · doi:10.1111/adb.2010.15.issue-4
- 10.1111/jne.1991.3.issue-5 · doi:10.1111/jne.1991.3.issue-5
- 10.1002/da.2012.29.issue-11 · doi:10.1002/da.2012.29.issue-11
- Jesova D., 1996, Acta Neurobiologiae Experimentalis, 56, 779
- 10.1111/acer.2013.37.issue-3 · doi:10.1111/acer.2013.37.issue-3
- 10.1111/adb.2011.16.issue-2 · doi:10.1111/adb.2011.16.issue-2
- Smyth B. P., 2010, Irish Medical Journal, 103, 176
- 10.1111/psyp.2007.44.issue-3 · doi:10.1111/psyp.2007.44.issue-3
Cited by
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Craving and opioid use disorder: A scoping review
Kleykamp, B. A., Santis, M. D., Dworkin, R. H., Huhn, A. S., Kampman, K. M., Montoya, I. D., Preston, K. L., Ramey, T. S., Smith, S. M., Turk, D. C., et al. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107639 · Cited by 63
Zhang, M., Liu, S., Wang, S., Xu, Y., Chen, L., Shao, Z., Wen, X., Yang, W., Liu, J., & Yuan, K. (2021) · Human Brain Mapping · doi:10.1002/hbm.25346 · Cited by 28
Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol
Kudrich, C., Hurd, Y. L., Salsitz, E. A., & Wang, A. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0089 · Cited by 25
Decreased Blood Levels of Oxytocin in Ketamine-Dependent Patients During Early Abstinence
Huang, M., Chen, L., Chang, H., Liang, X., Chen, C., Cheng, W., & Xu, K. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00633 · Cited by 22
Metadata
- Authors
- Nikolaou, K., Kapoukranidou, D., Ndungu, S., Floros, G., & Kovatsi, L.
- Affiliations
- G. Papanikolaou General Hospital (GR)
- Associate Professor, Department of Physiology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
- Aristotle University of Thessaloniki (GR)
- Corresponding author
- Kovatsi, Leda
- Venue
- Journal of Psychoactive Drugs
- Publisher
- Informa UK Limited
- Published
- 2017-04-26
- Volume
- 49
- Issue
- 3
- Pages
- 233-241
- ISSN
- 0279-1072 (ISSN-L)
- 2159-9777
- OpenAlex
- W2610111816
- Cited by
- 18
- References
- 92
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2021: 5 · 2020: 2 · 2019: 2 · 2018: 2
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychoactive Drugs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- heroin withdrawal, plasma oxytocin, chronic opioid users, treatment discontinuation, withdrawal symptoms, craving, anxiety, depression, Hamilton Anxiety Rating Scale
- MeSH terms
- Adult, Heroin Dependence, Humans, Male, Oxytocin, Patient Dropouts, Severity of Illness Index, Substance Withdrawal Syndrome, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Severity of Withdrawal Symptoms, Plasma Oxytocin Levels, and Treatment Outcome in Heroin Users Undergoing Acute Withdrawal. https://app.cochat.ai/papers/10.1080/02791072.2017.1312644
- The paper
- Nikolaou, K., Kapoukranidou, D., Ndungu, S., Floros, G., & Kovatsi, L. (2017). Severity of Withdrawal Symptoms, Plasma Oxytocin Levels, and Treatment Outcome in Heroin Users Undergoing Acute Withdrawal. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2017.1312644
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.